116 related articles for article (PubMed ID: 37605575)
1. Identification of ESM1 as a Potential Biomarker Involving Drug Sensitivity and the Tumor Immune Microenvironment that Promotes Proliferation of Melanoma.
Wang M; Ge H; Liang S; Chen G
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):160-167. PubMed ID: 37605575
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
[TBL] [Abstract][Full Text] [Related]
3. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
4. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
5. Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance.
Li YK; Zeng T; Guan Y; Liu J; Liao NC; Wang MJ; Chen KX; Luo XY; Chen CY; Quan FF; Wang J; Zhang QF; Zou J
Int J Biol Sci; 2023; 19(1):258-280. PubMed ID: 36594088
[No Abstract] [Full Text] [Related]
6. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer.
Pan KF; Lee WJ; Chou CC; Yang YC; Chang YC; Chien MH; Hsiao M; Hua KT
EMBO J; 2021 Feb; 40(4):e105450. PubMed ID: 33347625
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.
Bender O; Gunduz M; Cigdem S; Hatipoglu OF; Acar M; Kaya M; Grenman R; Gunduz E; Ugur KS
J Oral Pathol Med; 2018 Jan; 47(1):40-47. PubMed ID: 29024069
[TBL] [Abstract][Full Text] [Related]
9. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B
Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390
[TBL] [Abstract][Full Text] [Related]
10. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
11. Identifying
Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
[No Abstract] [Full Text] [Related]
12. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
Liang Z; Pan L; Shi J; Zhang L
Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
[TBL] [Abstract][Full Text] [Related]
13. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
14. Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients.
Si Z; Hu H
Med Sci Monit; 2021 Jul; 27():e932052. PubMed ID: 34247183
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
17. ESM1/HIF‑1α pathway modulates chronic intermittent hypoxia‑induced non‑small‑cell lung cancer proliferation, stemness and epithelial‑mesenchymal transition.
Gu X; Zhang J; Shi Y; Shen H; Li Y; Chen Y; Liang L
Oncol Rep; 2021 Mar; 45(3):1226-1234. PubMed ID: 33650648
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
Cai L; Leng ZG; Guo YH; Lin SJ; Wu ZR; Su ZP; Lu JL; Wei LF; Zhuge QC; Jin K; Wu ZB
Endocrine; 2016 Jun; 52(3):641-51. PubMed ID: 26662185
[TBL] [Abstract][Full Text] [Related]
19. ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
Calderaro J; Meunier L; Nguyen CT; Boubaya M; Caruso S; Luciani A; Amaddeo G; Regnault H; Nault JC; Cohen J; Oberti F; Michalak S; Bouattour M; Vilgrain V; Pageaux GP; Ramos J; Barget N; Guiu B; Paradis V; Aubé C; Laurent A; Pawlotsky JM; Ganne-Carrié N; Zucman-Rossi J; Seror O; Ziol M
Clin Cancer Res; 2019 Oct; 25(19):5859-5865. PubMed ID: 31358545
[TBL] [Abstract][Full Text] [Related]
20. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO.
Wen S; Peng W; Chen Y; Du X; Xia J; Shen B; Zhou G
BMC Cancer; 2022 Feb; 22(1):193. PubMed ID: 35184748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
